SYNTHESIS, STRUCTURAL CHARACTERIZATION AND IN-VITRO ANTITUMOR PROPERTIES OF TRIORGANOANTIMONY(V) DISALICYLATES - CRYSTAL AND MOLECULAR-STRUCTURES OF [5-Y-2-(HO)C(6)H3COO](2)SBME(3) (Y=H, ME, MEO)
C. Silvestru et al., SYNTHESIS, STRUCTURAL CHARACTERIZATION AND IN-VITRO ANTITUMOR PROPERTIES OF TRIORGANOANTIMONY(V) DISALICYLATES - CRYSTAL AND MOLECULAR-STRUCTURES OF [5-Y-2-(HO)C(6)H3COO](2)SBME(3) (Y=H, ME, MEO), Applied organometallic chemistry, 9(7), 1995, pp. 597-607
Triorganoantimony(V) salicylates, [5-Y-2-(HO)-C6H3COO](2)SbR(3) (R=Me,
Ph; Y=H, Me, MeO), were obtained by reacting R(3)SbCl(2) with the app
ropriate sodium salt. The compounds have been characterized by IR, MS,
H-1 and C-13 NMR spectroscopy. The molecular structure of the three s
ubstituted trimethylantimony(V) disalicylates has been determined by X
-ray diffraction. The salicylate ligands are mono-coordinated to antim
ony through an oxygen atom of each carboxylate, leading to a trigonal
bipyramidal geometry, with the antimony-methyl groups in equatorial po
sitions and the oxygen atoms in axial positions. The trimethylantimony
compounds tested in vitro against a series of human tumour cell Lines
were found to be inactive.